A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
From All of Us Research to All of Us in the Real World: Using the All of Us Research Program Data to Improve Population Health Thursday, September 29 | 9:30-11 a.m., ET | Virtual | Free, registration required Through a Data Use Agreement with the All of Us Research Program, scientists at the Centers for […]
Thursday, October 6 | 11 am-12 pm ET This seminar will review our emerging knowledge of the role of host genomic factors in the susceptibility and outcomes of COVID-19 infection, response to vaccines and treatments as well as long-term sequels of the disease. Speakers Jean-Laurent Casanova, M.D., Ph.D. and Jacques Fellay, M.D., Ph.D. will discuss […]
Explore the Exposome: The Next Frontier of Individualizing Medicine November 2-3, 2022 | Rochester, MN & Virtual When genomics alone cannot explain a disease, we enter the world of the exposome for insight. Attendees discover ways to innovate and advance care through genomics and emerging exposome science. Expert speakers from around the world and Mayo […]
GMKB